CaƱete, Liezel .
HRN: 25-30-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2024
CEFUROXIME 500MG (TAB)
06/18/2024
06/25/2024
PO
500 Mg Tab
BID
S/P LSCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes